AMPK targets PDZD8 to trigger carbon source shift from glucose to glutamine

AMPK靶向PDZD8,触发碳源从葡萄糖向谷氨酰胺的转变

阅读:5
作者:Mengqi Li # ,Yu Wang # ,Xiaoyan Wei # ,Wei-Feng Cai # ,Jianfeng Wu # ,Mingxia Zhu ,Yongliang Wang ,Yan-Hui Liu ,Jinye Xiong ,Qi Qu ,Yan Chen ,Xiao Tian ,Luming Yao ,Renxiang Xie ,Xiaomin Li ,Siwei Chen ,Xi Huang ,Cixiong Zhang ,Changchuan Xie ,Yaying Wu ,Zheni Xu ,Baoding Zhang ,Bin Jiang ,Zhi-Chao Wang ,Qinxi Li ,Gang Li ,Shu-Yong Lin ,Li Yu ,Hai-Long Piao ,Xianming Deng ,Jiahuai Han ,Chen-Song Zhang ,Sheng-Cai Lin

Abstract

The shift of carbon utilization from primarily glucose to other nutrients is a fundamental metabolic adaptation to cope with decreased blood glucose levels and the consequent decline in glucose oxidation. AMP-activated protein kinase (AMPK) plays crucial roles in this metabolic adaptation. However, the underlying mechanism is not fully understood. Here, we show that PDZ domain containing 8 (PDZD8), which we identify as a new substrate of AMPK activated in low glucose, is required for the low glucose-promoted glutaminolysis. AMPK phosphorylates PDZD8 at threonine 527 (T527) and promotes the interaction of PDZD8 with and activation of glutaminase 1 (GLS1), a rate-limiting enzyme of glutaminolysis. In vivo, the AMPK-PDZD8-GLS1 axis is required for the enhancement of glutaminolysis as tested in the skeletal muscle tissues, which occurs earlier than the increase in fatty acid utilization during fasting. The enhanced glutaminolysis is also observed in macrophages in low glucose or under acute lipopolysaccharide (LPS) treatment. Consistent with a requirement of heightened glutaminolysis, the PDZD8-T527A mutation dampens the secretion of pro-inflammatory cytokines in macrophages in mice treated with LPS. Together, we have revealed an AMPK-PDZD8-GLS1 axis that promotes glutaminolysis ahead of increased fatty acid utilization under glucose shortage.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。